Third Point LLC Sends Letter Requesting Removal of PDL BioPharma's (PDLI) CEO
Tweet Send to a Friend
In a letter sent today to the Board of Directors of PDL BioPharma, Inc. (Nasdaq: PDLI), Third Point LLC appealed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
